nodes	percent_of_prediction	percent_of_DWPC	metapath
Canagliflozin—ABCB1—Parkinson's disease	0.733	1	CbGaD
Canagliflozin—Dapagliflozin—CYP2D6—Parkinson's disease	0.00618	0.583	CrCbGaD
Canagliflozin—Dapagliflozin—ABCB1—Parkinson's disease	0.00441	0.417	CrCbGaD
Canagliflozin—ABCB1—Allograft Rejection—FASLG—Parkinson's disease	0.000246	0.00096	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—INS—Parkinson's disease	0.000245	0.000957	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—MTHFR—Parkinson's disease	0.000245	0.000956	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—CYP2E1—Parkinson's disease	0.000245	0.000954	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—CYP2E1—Parkinson's disease	0.000245	0.000954	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—NQO1—Parkinson's disease	0.000242	0.000944	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—NQO1—Parkinson's disease	0.000242	0.000944	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—TH—Parkinson's disease	0.000238	0.00093	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—TH—Parkinson's disease	0.000238	0.00093	CbGpPWpGaD
Canagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000238	0.000928	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000233	0.00091	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.00023	0.000898	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—CYCS—Parkinson's disease	0.000229	0.000893	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—CYCS—Parkinson's disease	0.000229	0.000893	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000229	0.000892	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—IL1B—Parkinson's disease	0.000225	0.000878	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—MCCC1—Parkinson's disease	0.00022	0.000857	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ND3—Parkinson's disease	0.00022	0.000857	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000219	0.000854	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000219	0.000854	CbGpPWpGaD
Canagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000217	0.000848	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000216	0.000844	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.00021	0.00082	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—TALDO1—Parkinson's disease	0.000207	0.000806	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—CYP2D6—Parkinson's disease	0.000207	0.000806	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—OMD—Parkinson's disease	0.000207	0.000806	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—CTGF—Parkinson's disease	0.000203	0.000791	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—COMT—Parkinson's disease	0.000203	0.000791	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—COMT—Parkinson's disease	0.000203	0.000791	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—GSTP1—Parkinson's disease	0.000202	0.000787	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—GSTP1—Parkinson's disease	0.000202	0.000787	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—MAOA—Parkinson's disease	0.000201	0.000785	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—MAOA—Parkinson's disease	0.000201	0.000785	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—FGB—Parkinson's disease	0.000199	0.000777	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000199	0.000777	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—HMOX1—Parkinson's disease	0.000199	0.000776	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—HMOX1—Parkinson's disease	0.000199	0.000776	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—NDUFB11—Parkinson's disease	0.000196	0.000764	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000196	0.000763	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—MTHFR—Parkinson's disease	0.000196	0.000763	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—MTHFR—Parkinson's disease	0.000196	0.000763	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—INS—Parkinson's disease	0.000195	0.00076	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000192	0.000748	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000192	0.000748	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ABCB1—Parkinson's disease	0.000191	0.000745	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ABCB1—Parkinson's disease	0.000191	0.000745	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000191	0.000744	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—CYP2E1—Parkinson's disease	0.000189	0.000737	CbGpPWpGaD
Canagliflozin—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000188	0.000734	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GCH1—Parkinson's disease	0.000187	0.000729	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—NQO1—Parkinson's disease	0.000187	0.000729	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—GSTM1—Parkinson's disease	0.000185	0.000723	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—GSTM1—Parkinson's disease	0.000185	0.000723	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—TH—Parkinson's disease	0.000184	0.000718	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IL1B—Parkinson's disease	0.000183	0.000714	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—APOE—Parkinson's disease	0.000182	0.000711	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—APOE—Parkinson's disease	0.000182	0.000711	CbGpPWpGaD
Canagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000179	0.000698	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—GPX1—Parkinson's disease	0.000178	0.000693	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—GPX1—Parkinson's disease	0.000178	0.000693	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—CYCS—Parkinson's disease	0.000177	0.000689	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.00017	0.000663	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000168	0.000657	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—FBP1—Parkinson's disease	0.000166	0.000649	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GBA—Parkinson's disease	0.000166	0.000649	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—DBH—Parkinson's disease	0.000166	0.000649	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—MTHFR—Parkinson's disease	0.000164	0.000639	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—MTHFR—Parkinson's disease	0.000164	0.000639	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—TNF—Parkinson's disease	0.000163	0.000637	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—MAG—Parkinson's disease	0.000163	0.000636	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—COMT—Parkinson's disease	0.000157	0.000611	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—GSTP1—Parkinson's disease	0.000156	0.000608	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—INS—Parkinson's disease	0.000156	0.000607	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—INS—Parkinson's disease	0.000156	0.000607	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—MAOA—Parkinson's disease	0.000155	0.000606	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—HMOX1—Parkinson's disease	0.000154	0.000599	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—APOE—Parkinson's disease	0.000153	0.000595	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—APOE—Parkinson's disease	0.000153	0.000595	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.00015	0.000585	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	0.000148	0.000577	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ABCB1—Parkinson's disease	0.000147	0.000575	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.000145	0.000567	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—GSTM1—Parkinson's disease	0.000143	0.000558	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000142	0.000554	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	0.000141	0.000548	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000139	0.000542	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	0.000139	0.000542	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	0.000139	0.000541	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—GPX1—Parkinson's disease	0.000137	0.000535	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000137	0.000534	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000136	0.000532	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—TNF—Parkinson's disease	0.000133	0.000518	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	0.000133	0.000518	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—IL6—Parkinson's disease	0.000132	0.000514	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—INS—Parkinson's disease	0.00013	0.000508	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—INS—Parkinson's disease	0.00013	0.000508	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—MTHFR—Parkinson's disease	0.000127	0.000494	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000126	0.000493	CbGpPWpGaD
Canagliflozin—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000125	0.000486	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—DDC—Parkinson's disease	0.000122	0.000477	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000122	0.000476	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000121	0.000474	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000118	0.000462	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—APOE—Parkinson's disease	0.000118	0.000459	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000116	0.000453	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000116	0.000451	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GSTA4—Parkinson's disease	0.000115	0.00045	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—MCCC1—Parkinson's disease	0.000115	0.000449	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ND3—Parkinson's disease	0.000115	0.000449	CbGpPWpGaD
Canagliflozin—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000114	0.000444	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000114	0.000444	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000114	0.000443	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—TALDO1—Parkinson's disease	0.000108	0.000422	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—OMD—Parkinson's disease	0.000108	0.000422	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IL6—Parkinson's disease	0.000107	0.000418	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000107	0.000417	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—TNF—Parkinson's disease	0.000106	0.000412	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PLA2G6—Parkinson's disease	0.000104	0.000405	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—MAOB—Parkinson's disease	0.000103	0.000401	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—FGB—Parkinson's disease	0.000103	0.000401	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—NDUFB11—Parkinson's disease	0.000102	0.0004	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000102	0.000397	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—TNF—Parkinson's disease	0.000101	0.000393	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ND3—Parkinson's disease	0.000101	0.000393	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—MCCC1—Parkinson's disease	0.000101	0.000393	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—INS—Parkinson's disease	0.000101	0.000392	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	9.79e-05	0.000382	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GCH1—Parkinson's disease	9.78e-05	0.000381	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—COMT—Parkinson's disease	9.57e-05	0.000373	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	9.53e-05	0.000372	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	9.51e-05	0.000371	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—OMD—Parkinson's disease	9.47e-05	0.00037	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—TALDO1—Parkinson's disease	9.47e-05	0.00037	CbGpPWpGaD
Canagliflozin—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	9.44e-05	0.000368	CbGpPWpGaD
Canagliflozin—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	9.4e-05	0.000367	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	9.36e-05	0.000365	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NDUFB11—Parkinson's disease	8.98e-05	0.00035	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	8.82e-05	0.000344	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	8.76e-05	0.000342	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—DBH—Parkinson's disease	8.72e-05	0.00034	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GBA—Parkinson's disease	8.72e-05	0.00034	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—FBP1—Parkinson's disease	8.72e-05	0.00034	CbGpPWpGaD
Canagliflozin—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	8.64e-05	0.000337	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GCH1—Parkinson's disease	8.57e-05	0.000334	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	8.52e-05	0.000332	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CYP2D6—Parkinson's disease	7.64e-05	0.000298	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—FBP1—Parkinson's disease	7.64e-05	0.000298	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—DBH—Parkinson's disease	7.64e-05	0.000298	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GBA—Parkinson's disease	7.64e-05	0.000298	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—SOD1—Parkinson's disease	7.63e-05	0.000298	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	7.61e-05	0.000297	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CTGF—Parkinson's disease	7.5e-05	0.000293	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	7.31e-05	0.000285	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—ABL1—Parkinson's disease	7.28e-05	0.000284	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—IGF2—Parkinson's disease	7.24e-05	0.000283	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CYP2E1—Parkinson's disease	6.99e-05	0.000273	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—NQO1—Parkinson's disease	6.91e-05	0.00027	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—HGF—Parkinson's disease	6.84e-05	0.000267	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	6.84e-05	0.000267	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—TH—Parkinson's disease	6.81e-05	0.000266	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—IL6—Parkinson's disease	6.8e-05	0.000265	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—IL6—Parkinson's disease	6.8e-05	0.000265	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	6.67e-05	0.00026	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CYCS—Parkinson's disease	6.54e-05	0.000255	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.41e-05	0.00025	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—DDC—Parkinson's disease	6.4e-05	0.00025	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.36e-05	0.000248	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	6.29e-05	0.000245	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—MCCC1—Parkinson's disease	6.21e-05	0.000242	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ND3—Parkinson's disease	6.21e-05	0.000242	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.1e-05	0.000238	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GSTA4—Parkinson's disease	6.04e-05	0.000236	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	5.96e-05	0.000233	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—TALDO1—Parkinson's disease	5.84e-05	0.000228	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—OMD—Parkinson's disease	5.84e-05	0.000228	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—COMT—Parkinson's disease	5.79e-05	0.000226	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GSTP1—Parkinson's disease	5.76e-05	0.000225	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—MAOA—Parkinson's disease	5.75e-05	0.000224	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—HMOX1—Parkinson's disease	5.69e-05	0.000222	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—DDC—Parkinson's disease	5.6e-05	0.000219	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.57e-05	0.000217	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	5.53e-05	0.000216	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ABCB1—Parkinson's disease	5.46e-05	0.000213	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PLA2G6—Parkinson's disease	5.44e-05	0.000212	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—MAOB—Parkinson's disease	5.38e-05	0.00021	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GSTM1—Parkinson's disease	5.3e-05	0.000207	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GSTA4—Parkinson's disease	5.29e-05	0.000206	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GCH1—Parkinson's disease	5.28e-05	0.000206	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	5.12e-05	0.0002	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GPX1—Parkinson's disease	5.07e-05	0.000198	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	4.97e-05	0.000194	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PLA2G6—Parkinson's disease	4.77e-05	0.000186	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—MAOB—Parkinson's disease	4.72e-05	0.000184	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GBA—Parkinson's disease	4.7e-05	0.000184	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—FBP1—Parkinson's disease	4.7e-05	0.000184	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—DBH—Parkinson's disease	4.7e-05	0.000184	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—MTHFR—Parkinson's disease	4.68e-05	0.000183	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—APOE—Parkinson's disease	4.36e-05	0.00017	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CYP2D6—Parkinson's disease	4e-05	0.000156	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CTGF—Parkinson's disease	3.93e-05	0.000153	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—INS—Parkinson's disease	3.72e-05	0.000145	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CYP2E1—Parkinson's disease	3.66e-05	0.000143	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—NQO1—Parkinson's disease	3.62e-05	0.000141	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—TH—Parkinson's disease	3.57e-05	0.000139	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CYP2D6—Parkinson's disease	3.51e-05	0.000137	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—DDC—Parkinson's disease	3.45e-05	0.000135	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CTGF—Parkinson's disease	3.44e-05	0.000134	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CYCS—Parkinson's disease	3.42e-05	0.000134	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GSTA4—Parkinson's disease	3.26e-05	0.000127	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CYP2E1—Parkinson's disease	3.21e-05	0.000125	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NQO1—Parkinson's disease	3.17e-05	0.000124	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—TH—Parkinson's disease	3.13e-05	0.000122	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—COMT—Parkinson's disease	3.03e-05	0.000118	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GSTP1—Parkinson's disease	3.02e-05	0.000118	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—MAOA—Parkinson's disease	3.01e-05	0.000117	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CYCS—Parkinson's disease	3e-05	0.000117	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—HMOX1—Parkinson's disease	2.98e-05	0.000116	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.94e-05	0.000115	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.91e-05	0.000113	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ABCB1—Parkinson's disease	2.86e-05	0.000111	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GSTM1—Parkinson's disease	2.77e-05	0.000108	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—COMT—Parkinson's disease	2.66e-05	0.000104	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GPX1—Parkinson's disease	2.66e-05	0.000104	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GSTP1—Parkinson's disease	2.64e-05	0.000103	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—MAOA—Parkinson's disease	2.64e-05	0.000103	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—HMOX1—Parkinson's disease	2.61e-05	0.000102	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—MTHFR—Parkinson's disease	2.45e-05	9.56e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.43e-05	9.48e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GPX1—Parkinson's disease	2.33e-05	9.08e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—APOE—Parkinson's disease	2.28e-05	8.9e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	2.16e-05	8.43e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—MTHFR—Parkinson's disease	2.15e-05	8.38e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CTGF—Parkinson's disease	2.12e-05	8.27e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—APOE—Parkinson's disease	2e-05	7.8e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.98e-05	7.71e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.95e-05	7.62e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—INS—Parkinson's disease	1.95e-05	7.61e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—TH—Parkinson's disease	1.93e-05	7.51e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.85e-05	7.21e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—INS—Parkinson's disease	1.71e-05	6.66e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—COMT—Parkinson's disease	1.64e-05	6.39e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.63e-05	6.36e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.63e-05	6.34e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.61e-05	6.27e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.54e-05	6.02e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.5e-05	5.84e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.43e-05	5.59e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.32e-05	5.16e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—APOE—Parkinson's disease	1.23e-05	4.81e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—INS—Parkinson's disease	1.05e-05	4.11e-05	CbGpPWpGaD
